Indeed, MDM4 amplification was found to be enriched in the TP53-phenocopying group of tumor samples, but not in the rest of tumor groups – the TP53 mutant and the non-phenocopying TP53 wild-type (Fig. 2b). Here, MDM4 is linked to neoplasm.